EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma

Neja Šamec iD, Gloria Krapež iD, Cene Skubic, Ivana Jovčevska iD, Alja Videtič Paska iD

Metabolites · 29.04.2025 · 15 (5) · 295

DOI: 10.3390/metabo15050295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 29.04.2025. Verfasst von Neja Šamec und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Functional Genomics and Biochips, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Zaloška …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency, Slovenian Research and Innovation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: In recent years, interest in studying changes in cancer metabolites has resulted in significant advances in the metabolomics field. Glioblastoma remains the most aggressive and lethal brain malignancy, which presents with notable metabolic reprogramming.

Methods

We performed literature research from the PubMed database and considered research articles focused on the key metabolic pathways altered in glioblastoma (e.g., glycolysis, lipid metabolism, TCA cycle), the role of oncometabolites and metabolic plasticity, and the differential expression of metabolites in glioblastoma. Currently used metabolomics approaches can be either targeted, focusing on specific metabolites and pathways, or untargeted, which involves data-driven exploration of the metabolome and also results in the identification of new metabolites. Data processing and analysis is of great importance and can be improved with the integration of machine learning approaches for metabolite identification.

Results

Changes in α/β-glucose, lactate, choline, and 2-hydroxyglutarate were detected in glioblastoma compared with non-tumor tissues. Different metabolites such as fumarate, tyrosine, and leucine, as well as citric acid, isocitric acid, shikimate, and GABA were detected in blood and CSF, respectively.

Conclusions

Although promising new technological and bioinformatic approaches help us understand glioblastoma better, challenges associated with biomarker availability, tumor heterogeneity, interpatient variability, standardization, and reproducibility still remain. Metabolomics research, either alone or combined with genomics or proteomics (i.e., multiomics) in glioblastoma, can lead to biomarker identification, tracking of metabolic therapy response, discovery of novel metabolites and pathways, and identification of potential therapeutic targets.

Schlagwörter

Stichwörter der Autor:innen

biomarkerdiagnosismetabolomemultiomic integrationomicsprecision oncologytherapytumor metabolic reprogramming

Autor:innen und Institutionen

  • Centre for Functional Genomics and Biochips, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Zaloška Cesta 4, 1000 Ljubljana, Slovenia.

ORCID-Profile: Neja Šamec, Gloria Krapež, Ivana Jovčevska, Alja Videtič Paska

Förderung

  • The Slovenian Research and Innovation Agency
  • Slovenian Research and Innovation Agency

Zitieren

APA

Šamec, N., Krapež, G., Skubic, C., Jovčevska, I., & Videtič Paska, A. (2025). From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma. Metabolites, 15(5), 295. https://doi.org/10.3390/metabo15050295

Vancouver

Šamec N, Krapež G, Skubic C, Jovčevska I, Videtič Paska A. From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma. Metabolites. 2025;15(5):295. doi:10.3390/metabo15050295

BibTeX
@article{amec2025,
  author = {Šamec, Neja and Krapež, Gloria and Skubic, Cene and Jovčevska, Ivana and Videtič Paska, Alja},
  title = {From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {295},
  doi = {10.3390/metabo15050295}
}
Kostenlos starten →